Click for best price
Endometrial Cancer Market Size, Share 2022
Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It is the result of the abnormal growth of cells that have the ability to invade or spread to Others parts of the body. The first sign is most often vaginal bleeding not associated with a menstrual period. Others symptoms include pain with urination, pain during sexual intercourse, or pelvic pain. Endometrial cancer occurs most commonly after menopause.
This report contains market size and forecasts of Endometrial Cancer in Global, including the following market information:
Global Endometrial Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Endometrial Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hysterectomy Techniques Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Endometrial Cancer include Pfizer, Johnson & Johnson, Boston Scientific, GE, Karl Storz, Koninklijke Philips, Celgene, Lupin and LiNA Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Endometrial Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Endometrial Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Endometrial Cancer Market Segment Percentages, by Type, 2021 (%)
Hysterectomy Techniques
Radiation
Hormone Therapy
ChemOthersapy
Global Endometrial Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Endometrial Cancer Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Gynecology Centers
Others
Global Endometrial Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Endometrial Cancer Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Endometrial Cancer revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Endometrial Cancer revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
Boston Scientific
GE
Karl Storz
Koninklijke Philips
Celgene
Lupin
LiNA Medical
Bayer AG
Cooper Surgical
Hologic
| Report Attributes |
Report Details |
| Report Title |
Endometrial Cancer Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Endometrial Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Endometrial Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Endometrial Cancer Overall Market Size
2.1 Global Endometrial Cancer Market Size: 2021 VS 2028
2.2 Global Endometrial Cancer Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Endometrial Cancer Players in Global Market
3.2 Top Global Endometrial Cancer Companies Ranked by Revenue
3.3 Global Endometrial Cancer Revenue by Companies
3.4 Top 3 and Top 5 Endometrial Cancer Companies in Global Market, by Revenue in 2021
3.5 Global Companies Endometrial Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Endometrial Cancer Players in Global Market
3.6.1 List of Global Tier 1 Endometrial Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Endometrial Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Endometrial Cancer Market Size Markets, 2021 & 2028
4.1.2 Hysterectomy Techniques
4.1.3 Radiation
4.1.4 Hormone Therapy
4.1.5 ChemOthersapy
4.2 By Type - Global Endometrial Cancer Revenue & Forecasts
4.2.1 By Type - Global Endometrial Cancer Revenue, 2017-2022
4.2.2 By Type - Global Endometrial Cancer Revenue, 2023-2028
4.2.3 By Type - Global Endometrial Cancer Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Endometrial Cancer Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Gynecology Centers
5.1.5 Others
5.2 By Application - Global Endometrial Cancer Revenue & Forecasts
5.2.1 By Application - Global Endometrial Cancer Revenue, 2017-2022
5.2.2 By Application - Global Endometrial Cancer Revenue, 2023-2028
5.2.3 By Application - Global Endometrial Cancer Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Endometrial Cancer Market Size, 2021 & 2028
6.2 By Region - Global Endometrial Cancer Revenue & Forecasts
6.2.1 By Region - Global Endometrial Cancer Revenue, 2017-2022
6.2.2 By Region - Global Endometrial Cancer Revenue, 2023-2028
6.2.3 By Region - Global Endometrial Cancer Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Endometrial Cancer Revenue, 2017-2028
6.3.2 US Endometrial Cancer Market Size, 2017-2028
6.3.3 Canada Endometrial Cancer Market Size, 2017-2028
6.3.4 Mexico Endometrial Cancer Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Endometrial Cancer Revenue, 2017-2028
6.4.2 Germany Endometrial Cancer Market Size, 2017-2028
6.4.3 France Endometrial Cancer Market Size, 2017-2028
6.4.4 U.K. Endometrial Cancer Market Size, 2017-2028
6.4.5 Italy Endometrial Cancer Market Size, 2017-2028
6.4.6 Russia Endometrial Cancer Market Size, 2017-2028
6.4.7 Nordic Countries Endometrial Cancer Market Size, 2017-2028
6.4.8 Benelux Endometrial Cancer Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Endometrial Cancer Revenue, 2017-2028
6.5.2 China Endometrial Cancer Market Size, 2017-2028
6.5.3 Japan Endometrial Cancer Market Size, 2017-2028
6.5.4 South Korea Endometrial Cancer Market Size, 2017-2028
6.5.5 Southeast Asia Endometrial Cancer Market Size, 2017-2028
6.5.6 India Endometrial Cancer Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Endometrial Cancer Revenue, 2017-2028
6.6.2 Brazil Endometrial Cancer Market Size, 2017-2028
6.6.3 Argentina Endometrial Cancer Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Endometrial Cancer Revenue, 2017-2028
6.7.2 Turkey Endometrial Cancer Market Size, 2017-2028
6.7.3 Israel Endometrial Cancer Market Size, 2017-2028
6.7.4 Saudi Arabia Endometrial Cancer Market Size, 2017-2028
6.7.5 UAE Endometrial Cancer Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Endometrial Cancer Major Product Offerings
7.1.4 Pfizer Endometrial Cancer Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Endometrial Cancer Major Product Offerings
7.2.4 Johnson & Johnson Endometrial Cancer Revenue in Global Market (2017-2022)
7.2.5 Johnson & Johnson Key News
7.3 Boston Scientific
7.3.1 Boston Scientific Corporate Summary
7.3.2 Boston Scientific Business Overview
7.3.3 Boston Scientific Endometrial Cancer Major Product Offerings
7.3.4 Boston Scientific Endometrial Cancer Revenue in Global Market (2017-2022)
7.3.5 Boston Scientific Key News
7.4 GE
7.4.1 GE Corporate Summary
7.4.2 GE Business Overview
7.4.3 GE Endometrial Cancer Major Product Offerings
7.4.4 GE Endometrial Cancer Revenue in Global Market (2017-2022)
7.4.5 GE Key News
7.5 Karl Storz
7.5.1 Karl Storz Corporate Summary
7.5.2 Karl Storz Business Overview
7.5.3 Karl Storz Endometrial Cancer Major Product Offerings
7.5.4 Karl Storz Endometrial Cancer Revenue in Global Market (2017-2022)
7.5.5 Karl Storz Key News
7.6 Koninklijke Philips
7.6.1 Koninklijke Philips Corporate Summary
7.6.2 Koninklijke Philips Business Overview
7.6.3 Koninklijke Philips Endometrial Cancer Major Product Offerings
7.6.4 Koninklijke Philips Endometrial Cancer Revenue in Global Market (2017-2022)
7.6.5 Koninklijke Philips Key News
7.7 Celgene
7.7.1 Celgene Corporate Summary
7.7.2 Celgene Business Overview
7.7.3 Celgene Endometrial Cancer Major Product Offerings
7.7.4 Celgene Endometrial Cancer Revenue in Global Market (2017-2022)
7.7.5 Celgene Key News
7.8 Lupin
7.8.1 Lupin Corporate Summary
7.8.2 Lupin Business Overview
7.8.3 Lupin Endometrial Cancer Major Product Offerings
7.8.4 Lupin Endometrial Cancer Revenue in Global Market (2017-2022)
7.8.5 Lupin Key News
7.9 LiNA Medical
7.9.1 LiNA Medical Corporate Summary
7.9.2 LiNA Medical Business Overview
7.9.3 LiNA Medical Endometrial Cancer Major Product Offerings
7.9.4 LiNA Medical Endometrial Cancer Revenue in Global Market (2017-2022)
7.9.5 LiNA Medical Key News
7.10 Bayer AG
7.10.1 Bayer AG Corporate Summary
7.10.2 Bayer AG Business Overview
7.10.3 Bayer AG Endometrial Cancer Major Product Offerings
7.10.4 Bayer AG Endometrial Cancer Revenue in Global Market (2017-2022)
7.10.5 Bayer AG Key News
7.11 Cooper Surgical
7.11.1 Cooper Surgical Corporate Summary
7.11.2 Cooper Surgical Business Overview
7.11.3 Cooper Surgical Endometrial Cancer Major Product Offerings
7.11.4 Cooper Surgical Endometrial Cancer Revenue in Global Market (2017-2022)
7.11.5 Cooper Surgical Key News
7.12 Hologic
7.12.1 Hologic Corporate Summary
7.12.2 Hologic Business Overview
7.12.3 Hologic Endometrial Cancer Major Product Offerings
7.12.4 Hologic Endometrial Cancer Revenue in Global Market (2017-2022)
7.12.5 Hologic Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Endometrial Cancer Market Opportunities & Trends in Global Market
Table 2. Endometrial Cancer Market Drivers in Global Market
Table 3. Endometrial Cancer Market Restraints in Global Market
Table 4. Key Players of Endometrial Cancer in Global Market
Table 5. Top Endometrial Cancer Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Endometrial Cancer Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Endometrial Cancer Revenue Share by Companies, 2017-2022
Table 8. Global Companies Endometrial Cancer Product Type
Table 9. List of Global Tier 1 Endometrial Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Endometrial Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Endometrial Cancer Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Endometrial Cancer Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Endometrial Cancer Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Endometrial Cancer Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Endometrial Cancer Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Endometrial Cancer Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Endometrial Cancer Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Endometrial Cancer Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Endometrial Cancer Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Endometrial Cancer Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Endometrial Cancer Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Endometrial Cancer Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Endometrial Cancer Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Endometrial Cancer Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Endometrial Cancer Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Endometrial Cancer Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Endometrial Cancer Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Endometrial Cancer Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Endometrial Cancer Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Endometrial Cancer Product Offerings
Table 32. Pfizer Endometrial Cancer Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Endometrial Cancer Product Offerings
Table 35. Johnson & Johnson Endometrial Cancer Revenue (US$, Mn), (2017-2022)
Table 36. Boston Scientific Corporate Summary
Table 37. Boston Scientific Endometrial Cancer Product Offerings
Table 38. Boston Scientific Endometrial Cancer Revenue (US$, Mn), (2017-2022)
Table 39. GE Corporate Summary
Table 40. GE Endometrial Cancer Product Offerings
Table 41. GE Endometrial Cancer Revenue (US$, Mn), (2017-2022)
Table 42. Karl Storz Corporate Summary
Table 43. Karl Storz Endometrial Cancer Product Offerings
Table 44. Karl Storz Endometrial Cancer Revenue (US$, Mn), (2017-2022)
Table 45. Koninklijke Philips Corporate Summary
Table 46. Koninklijke Philips Endometrial Cancer Product Offerings
Table 47. Koninklijke Philips Endometrial Cancer Revenue (US$, Mn), (2017-2022)
Table 48. Celgene Corporate Summary
Table 49. Celgene Endometrial Cancer Product Offerings
Table 50. Celgene Endometrial Cancer Revenue (US$, Mn), (2017-2022)
Table 51. Lupin Corporate Summary
Table 52. Lupin Endometrial Cancer Product Offerings
Table 53. Lupin Endometrial Cancer Revenue (US$, Mn), (2017-2022)
Table 54. LiNA Medical Corporate Summary
Table 55. LiNA Medical Endometrial Cancer Product Offerings
Table 56. LiNA Medical Endometrial Cancer Revenue (US$, Mn), (2017-2022)
Table 57. Bayer AG Corporate Summary
Table 58. Bayer AG Endometrial Cancer Product Offerings
Table 59. Bayer AG Endometrial Cancer Revenue (US$, Mn), (2017-2022)
Table 60. Cooper Surgical Corporate Summary
Table 61. Cooper Surgical Endometrial Cancer Product Offerings
Table 62. Cooper Surgical Endometrial Cancer Revenue (US$, Mn), (2017-2022)
Table 63. Hologic Corporate Summary
Table 64. Hologic Endometrial Cancer Product Offerings
Table 65. Hologic Endometrial Cancer Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Endometrial Cancer Segment by Type in 2021
Figure 2. Endometrial Cancer Segment by Application in 2021
Figure 3. Global Endometrial Cancer Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Endometrial Cancer Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Endometrial Cancer Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Endometrial Cancer Revenue in 2021
Figure 8. By Type - Global Endometrial Cancer Revenue Market Share, 2017-2028
Figure 9. By Application - Global Endometrial Cancer Revenue Market Share, 2017-2028
Figure 10. By Region - Global Endometrial Cancer Revenue Market Share, 2017-2028
Figure 11. By Country - North America Endometrial Cancer Revenue Market Share, 2017-2028
Figure 12. US Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Endometrial Cancer Revenue Market Share, 2017-2028
Figure 16. Germany Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 17. France Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Endometrial Cancer Revenue Market Share, 2017-2028
Figure 24. China Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 28. India Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Endometrial Cancer Revenue Market Share, 2017-2028
Figure 30. Brazil Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Endometrial Cancer Revenue Market Share, 2017-2028
Figure 33. Turkey Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Endometrial Cancer Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Boston Scientific Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GE Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Karl Storz Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Koninklijke Philips Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Celgene Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Lupin Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. LiNA Medical Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Bayer AG Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Cooper Surgical Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Hologic Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
